To the Editor: Cetuximab given concurrently with radiotherapyhas recently been reported to result in a survival benefit forpatients with locally advanced squamous-cell carcinoma of thehead and neck, without increasing the toxic effects of radiotherapy.1We report two cases of severe radiation dermatitis during thecourse of radiotherapy for squamous-cell carcinoma of the headand neck with concomitant use of cetuximab; these two casesof dermatitis occurred among five patients treated accordingto this protocol at our institution.
Patient 1 was a 57-year-old woman with grade 2 squamous-cellcarcinoma of the head and neck (cT3cN0cM0), and Patient 2 . . . [Full Text of this Article]
Mielke, F, Schneider-Obermeyer, J, Dorner, T
(2008). Onset of psoriasis with psoriatic arthropathy during rituximab treatment of non-Hodgkin lymphoma. Ann Rheum Dis
67: 1056-1057
[Full Text]
Gerber, P. A., Enderlein, E., Homey, B.
(2008). The Koebner-Phenomenon in Epidermal Growth Factor Receptor Inhibitor-Induced Cutaneous Adverse Effects. JCO
26: 2790-2792
[Full Text]
Bonner, J. A., Ang, K., Budach, W., Bolke, E., Homey, B.
(2007). More on Severe Cutaneous Reaction with Radiotherapy and Cetuximab. NEJM
357: 1872-1873
[Full Text]